State Codes and Statutes
Statutes > Utah > Title-58 > Chapter-38a > 58-38a-20358-38a-203. Duties of the committee.
(1) The committee serves as a consultative and advisory body to the Legislatureregarding:
(a) the movement of a controlled substance from one schedule to another;
(b) the removal of a controlled substance from any schedule; and
(c) the designation of a substance as a controlled substance and the placement of thesubstance in a designated schedule.
(2) On or before September 30 of each year, the committee shall submit to the Healthand Human Services Interim Committee a written report:
(a) listing any substances recommended by the committee for scheduling, rescheduling,or deletion from the schedules by the Legislature; and
(b) stating the reasons for the recommendation.
(3) In advising the Legislature regarding the need to add, delete, or reschedule asubstance, the committee shall consider:
(a) the actual or probable abuse of the substance, including:
(i) the history and current pattern of abuse both in Utah and in other states;
(ii) the scope, duration, and significance of abuse;
(iii) the degree of actual or probable detriment to public health which may result fromabuse of the substance;
(iv) the probable physical and social impact of widespread abuse of the substance;
(b) the biomedical hazard of the substance, including:
(i) its pharmacology, including the effects and modifiers of the effects of the substance;
(ii) its toxicology, acute and chronic toxicity, interaction with other substances, whethercontrolled or not, and the degree to which it may cause psychological or physiologicaldependence; and
(iii) the risk to public health and the particular susceptibility of segments of thepopulation;
(c) whether the substance is an immediate precursor, as defined in Section 58-37-2, of asubstance that is currently a controlled substance;
(d) the current state of scientific knowledge regarding the substance, including whetherthere is any acceptable means to safely use the substance under medical supervision;
(e) the relationship between the use of the substance and criminal activity, includingwhether:
(i) persons engaged in illicit trafficking of the substance are also engaged in othercriminal activity;
(ii) the nature and relative profitability of manufacturing or delivering the substanceencourages illicit trafficking in the substance;
(iii) the commission of other crimes is one of the recognized effects of abuse of thesubstance; and
(iv) addiction to the substance relates to the commission of crimes to facilitate thecontinued use of the substance;
(f) whether the substance has been scheduled by other states; and
(g) whether the substance has any accepted medical use in treatment in the United States.
(4) The committee's duties under this chapter do not include tobacco products as definedin Section 59-14-102 or alcoholic beverages as defined in Section 32A-1-105.
Enacted by Chapter 231, 2010 General Session
